focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJUS.L Regulatory News (JUS)

  • There is currently no data for JUS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviews Jupiter US Smaller Companies (JUS)

29 Nov 2018 17:50

RNS Number : 9768I
Jupiter US Smaller Companies PLC
29 November 2018
 

 

London, UK, 29 November 2018

Edison issues review on Jupiter US Smaller Companies (JUS)

Jupiter US Smaller Companies (JUS) is managed by Robert Siddles, who aims to generate long-term capital growth, while preserving capital in periods of stock market weakness, from a diversified portfolio of mid- and small-cap US equities. Since October 2017, the manager has employed a tighter investment process, increasing JUS's portfolio concentration and enhancing the sell discipline. This has proved effective; since then, the trust has outperformed its US small-cap equity benchmark by more than 15pp. Relative performance has remained robust during recent months, which have been characterised by high levels of stock market volatility.

 

JUS is currently trading at an 11.0% discount to cum-income NAV, which is wider than the 6.6% to 10.0% range of averages over the past one, three, five and 10 years. The board actively manages the discount by repurchasing shares, aiming for a maximum 8% discount in normal market conditions. The significant improvement in the trust's performance since the investment process was tightened in October 2017 suggests there is scope for the discount to narrow. US smaller companies is a low-yielding asset class; hence, JUS does not pay a dividend.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Sarah Godfrey, +44 (0)20 3681 2519

 

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEAXFNALKPFFF
Date   Source Headline
14th Dec 20205:13 pmRNSTransaction in Own Shares
14th Dec 202011:47 amRNSNet Asset Value(s)
11th Dec 20205:14 pmRNSTransaction in Own Shares
11th Dec 202011:21 amRNSNet Asset Value(s)
10th Dec 20205:22 pmRNSTransaction in Own Shares
10th Dec 20203:42 pmRNSHolding(s) in Company
10th Dec 202010:24 amRNSNet Asset Value(s)
9th Dec 20205:40 pmRNSTransaction in Own Shares
9th Dec 20209:52 amRNSKepler Trust Intelligence: Manager change analysis
9th Dec 20209:35 amRNSNet Asset Value(s)
9th Dec 20207:00 amRNSChange of Investment Manager
8th Dec 20209:47 amRNSNet Asset Value(s)
7th Dec 202010:16 amRNSNet Asset Value(s)
4th Dec 202011:17 amRNSNet Asset Value(s)
3rd Dec 202010:00 amRNSNet Asset Value(s)
2nd Dec 20209:54 amRNSNet Asset Value(s)
1st Dec 20204:21 pmRNSHolding(s) in Company
1st Dec 202011:26 amRNSNet Asset Value(s)
30th Nov 202010:43 amRNSNet Asset Value(s)
27th Nov 202011:24 amRNSNet Asset Value(s)
26th Nov 202010:01 amRNSNet Asset Value(s)
25th Nov 20209:45 amRNSNet Asset Value(s)
24th Nov 20209:41 amRNSNet Asset Value(s)
23rd Nov 202010:37 amRNSNet Asset Value(s)
20th Nov 202010:15 amRNSNet Asset Value(s)
19th Nov 202010:21 amRNSNet Asset Value(s)
18th Nov 202010:05 amRNSNet Asset Value(s)
17th Nov 20203:48 pmRNSPortfolio Update
17th Nov 202011:08 amRNSNet Asset Value(s)
16th Nov 20209:54 amRNSNet Asset Value(s)
13th Nov 202010:03 amRNSNet Asset Value(s)
12th Nov 202010:30 amRNSNet Asset Value(s)
11th Nov 202010:01 amRNSNet Asset Value(s)
10th Nov 202011:20 amRNSNet Asset Value(s)
9th Nov 20205:15 pmRNSTransaction in Own Shares
9th Nov 20209:52 amRNSNet Asset Value(s)
6th Nov 202012:13 pmRNSNet Asset Value(s)
5th Nov 202010:01 amRNSNet Asset Value(s)
4th Nov 20209:51 amRNSNet Asset Value(s)
3rd Nov 20205:17 pmRNSTransaction in Own Shares
3rd Nov 20209:39 amRNSNet Asset Value(s)
2nd Nov 20205:29 pmRNSTransaction in Own Shares
2nd Nov 202010:42 amRNSNet Asset Value(s)
30th Oct 20205:53 pmRNSTotal Voting Rights
30th Oct 202010:57 amRNSNet Asset Value(s)
29th Oct 202010:23 amRNSNet Asset Value(s)
28th Oct 202010:37 amRNSNet Asset Value(s)
27th Oct 202011:11 amRNSNet Asset Value(s)
26th Oct 20201:03 pmRNSDirector/PDMR Shareholding
26th Oct 20209:22 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.